Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study.


Journal

Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162

Informations de publication

Date de publication:
01 03 2023
Historique:
received: 16 12 2021
pubmed: 7 5 2022
medline: 4 3 2023
entrez: 6 5 2022
Statut: ppublish

Résumé

Many patients with Crohn's disease (CD) require fecal diversion. To understand the long-term outcomes, we performed a multicenter review of the experience with retained excluded rectums. We reviewed the medical records of all CD patients between 1990 and 2014 who had undergone diversionary surgery with retention of the excluded rectum for at least 6 months and who had at least 2 years of postoperative follow-up. From all the CD patients in the institutions' databases, there were 197 who met all our inclusion criteria. A total of 92 (46.7%) of 197 patients ultimately underwent subsequent proctectomy, while 105 (53.3%) still had retained rectums at time of last follow-up. Among these 105 patients with retained rectums, 50 (47.6%) underwent reanastomosis, while the other 55 (52.4%) retained excluded rectums. Of these 55 patients whose rectums remained excluded, 20 (36.4%) were symptom-free, but the other 35 (63.6%) were symptomatic. Among the 50 patients who had been reconnected, 28 (56%) were symptom-free, while 22(44%) were symptomatic. From our entire cohort of 197 cases, 149 (75.6%) either ultimately lost their rectums or remained symptomatic with retained rectums, while only 28 (14.2%) of 197, and only 4 (5.9%) of 66 with initial perianal disease, were able to achieve reanastomosis without further problems. Four patients developed anorectal dysplasia or cancer. In this multicenter cohort of patients with CD who had fecal diversion, fewer than 15%, and only 6% with perianal disease, achieved reanastomosis without experiencing disease persistence. Patients with distal Crohn’s disease often undergo colon resection with a stoma to divert the intestinal stream from the rectum in hopes of achieving sufficient healing to allow ultimate re-establishment of intestinal continuity. Patients and practitioners alike should be aware of the long-term success rates of this procedure. Our retrospective study of 197 patients found that half required later proctectomy and an additional one-quarter remained symptomatic with excluded rectums. Only 14% remained symptom-free after reanastomosis, and only 6% if perianal disease was the initial surgical indication. These data provide estimation of long-term surgical outcomes.

Sections du résumé

BACKGROUND
Many patients with Crohn's disease (CD) require fecal diversion. To understand the long-term outcomes, we performed a multicenter review of the experience with retained excluded rectums.
METHODS
We reviewed the medical records of all CD patients between 1990 and 2014 who had undergone diversionary surgery with retention of the excluded rectum for at least 6 months and who had at least 2 years of postoperative follow-up.
RESULTS
From all the CD patients in the institutions' databases, there were 197 who met all our inclusion criteria. A total of 92 (46.7%) of 197 patients ultimately underwent subsequent proctectomy, while 105 (53.3%) still had retained rectums at time of last follow-up. Among these 105 patients with retained rectums, 50 (47.6%) underwent reanastomosis, while the other 55 (52.4%) retained excluded rectums. Of these 55 patients whose rectums remained excluded, 20 (36.4%) were symptom-free, but the other 35 (63.6%) were symptomatic. Among the 50 patients who had been reconnected, 28 (56%) were symptom-free, while 22(44%) were symptomatic. From our entire cohort of 197 cases, 149 (75.6%) either ultimately lost their rectums or remained symptomatic with retained rectums, while only 28 (14.2%) of 197, and only 4 (5.9%) of 66 with initial perianal disease, were able to achieve reanastomosis without further problems. Four patients developed anorectal dysplasia or cancer.
CONCLUSIONS
In this multicenter cohort of patients with CD who had fecal diversion, fewer than 15%, and only 6% with perianal disease, achieved reanastomosis without experiencing disease persistence.
Patients with distal Crohn’s disease often undergo colon resection with a stoma to divert the intestinal stream from the rectum in hopes of achieving sufficient healing to allow ultimate re-establishment of intestinal continuity. Patients and practitioners alike should be aware of the long-term success rates of this procedure. Our retrospective study of 197 patients found that half required later proctectomy and an additional one-quarter remained symptomatic with excluded rectums. Only 14% remained symptom-free after reanastomosis, and only 6% if perianal disease was the initial surgical indication. These data provide estimation of long-term surgical outcomes.

Autres résumés

Type: plain-language-summary (eng)
Patients with distal Crohn’s disease often undergo colon resection with a stoma to divert the intestinal stream from the rectum in hopes of achieving sufficient healing to allow ultimate re-establishment of intestinal continuity. Patients and practitioners alike should be aware of the long-term success rates of this procedure. Our retrospective study of 197 patients found that half required later proctectomy and an additional one-quarter remained symptomatic with excluded rectums. Only 14% remained symptom-free after reanastomosis, and only 6% if perianal disease was the initial surgical indication. These data provide estimation of long-term surgical outcomes.

Identifiants

pubmed: 35522225
pii: 6581899
doi: 10.1093/ibd/izac099
pmc: PMC10210615
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

417-422

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK124570
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

J Clin Gastroenterol. 1985 Feb;7(1):37-43
pubmed: 3980962
Dis Colon Rectum. 1981 Nov-Dec;24(8):639-43
pubmed: 7318633
Colorectal Dis. 2015 Oct;17(10):882-90
pubmed: 25885419
Inflamm Bowel Dis. 2019 Jan 10;25(2):377-384
pubmed: 30085111
J Pediatr Surg. 2018 Mar;53(3):472-476
pubmed: 28889960
Gut. 2006 Jun;55(6):749-53
pubmed: 16698746
Gastroenterology. 1985 Jun;88(6):1818-25
pubmed: 3922845
Colorectal Dis. 2001 Jul;3(4):232-7
pubmed: 12790965
Int J Colorectal Dis. 1998;13(5-6):256-9
pubmed: 9870172
Br J Surg. 2000 Aug;87(8):1063-6
pubmed: 10931051
Colorectal Dis. 2011 Feb;13(2):171-6
pubmed: 19863597
World J Surg. 2000 Oct;24(10):1258-62; discussion 1262-3
pubmed: 11071472
Colorectal Dis. 2015 Jan;17(1):66-72
pubmed: 25306934
Scand J Gastroenterol. 2004 Mar;39(3):232-7
pubmed: 15074392
Dig Dis Sci. 2017 Aug;62(8):2079-2086
pubmed: 28550490
Dis Colon Rectum. 1992 Aug;35(8):768-72
pubmed: 1644001
Clin Colon Rectal Surg. 2019 Jul;32(4):273-279
pubmed: 31275074
Colorectal Dis. 2003 Sep;5(5):490-5
pubmed: 12925087
Scand J Gastroenterol. 1999 Mar;34(3):280-6
pubmed: 10232873
Gut. 2012 Apr;61(4):622-9
pubmed: 22267595
Inflamm Bowel Dis. 2022 Mar 30;28(4):547-552
pubmed: 34076248

Auteurs

Gassan Kassim (G)

Division of Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Clara Yzet (C)

Division of Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Nilendra Nair (N)

Division of Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Anketse Debebe (A)

Division of Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Alexa Rendon (A)

Division of Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Jean-Frédéric Colombel (JF)

Division of Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Cindy Traboulsi (C)

University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.

David T Rubin (DT)

University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.

Annalisa Maroli (A)

Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.

Elisabetta Coppola (E)

Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.

Michele M Carvello (MM)

Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.

Nadat Ben David (N)

Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.

Francesca De Lucia (F)

Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.

Matteo Sacchi (M)

Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.

Silvio Danese (S)

Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.

Antonino Spinelli (A)

Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.

Meike M C Hirdes (MMC)

Division of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.

Joren Ten Hove (J)

Division of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.

Bas Oldenburg (B)

Division of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.

Aurada Cholapranee (A)

Division of Gastroenterology and Hepatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

Maxine Riter (M)

Division of Gastroenterology and Hepatology, Weill Cornell Medical College, NY, USA.

Dana Lukin (D)

Jill Roberts Center for IBD, Weill Cornell Medicine, NY, USA.

Ellen Scherl (E)

Jill Roberts Center for IBD, Weill Cornell Medicine, NY, USA.

Esen Eren (E)

Inflammatory Bowel Disease Center at NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA.

Keith S Sultan (KS)

Division of Gastroenterology and Hepatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

Jordan Axelrad (J)

Inflammatory Bowel Disease Center at NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA.

David B Sachar (DB)

Division of Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH